Rolling Out My 2020 Triple-Net Active Versus Passive Portfolios

Just 27 names make the cut, down from 48 last year, and 36 from my late September preview.

Buyers of Morgan Stanley Should Wait for Renewed Strength Before Jumping In

Let's review the charts and indicators, and then revisit them in a few weeks.

Market Psychology Turns More Cautionary

The ISEE Put/Call Ratio is now at a level that has presaged market corrections five times since 2012.

WestRock Is Set to Continue Its Rise Through Resistance

Here's how we'd play shares of the cardboard maker.

BP's Dividend Cut Was Painful, But Better Days Are on the Horizon

BP has become an appealing stock for income investors.

Boyband BTS Sees Management Company Shares Blow Up Then Implode

Chart-topping K-Pop septet accounts for 87.7% of business at Big Hit.

Sorrento Therapeutics Stock Is Not That Attractive Now

I like to look for more compelling setups.

2 Biotech Trades That Illustrate My Investing Strategy

Replimune Group and Akebia Therapeutics provide examples of how to approach stocks in the biotech sector.

Netflix Reports Earnings on Tuesday: 6 Key Things to Watch

Keep an eye on comments shared about Q4 demand trends, movie licensing activity and the expected 2021 impact of production halts.

Don't Waste Your Time Trying to Trade Big-Picture Predictions

It is unproductive to miss out on the current positive price action because you instead are focused on what may happen weeks or months from now.